An accelerator can measure startup progress by establishing a baseline at the beginning of the program and reassessing companies throughout the cohort. Changes in risks, evidence, business readiness, and completion of prioritized actions provide a more meaningful view of progress than attendance or participation alone.

Accelerators are usually very good at measuring what happens inside their programs. They know how many workshops founders attended, how many mentor meetings took place, which assignments were completed, and whether companies participated in Demo Day.

Those metrics are useful for understanding engagement and program delivery.

But they do not necessarily show whether the startups improved.

To measure startup progress in an accelerator, the program needs to establish where each company started, determine what needed to change, and measure whether those changes actually occurred during the cohort.

Start With a Startup Baseline

Progress requires a reference point.

At the beginning of the accelerator, each startup should establish a baseline assessment of its current condition. This provides an initial view of the company’s evidence, capabilities, business readiness, and most important risks.

The baseline matters because startups rarely enter an accelerator from the same position.

Even companies at similar stages can have very different risk structures. One may have strong customer demand but serious financial constraints. Another may have sufficient runway and a capable team but weak evidence of product-market fit. A third may be growing quickly while its operations are becoming increasingly fragile.

Measuring all three companies against identical milestones can hide those differences.

The baseline establishes the starting point from which meaningful change can be measured.

Diagnose Before Prescribing

Once the baseline is established, the accelerator can identify what each startup actually needs.

This is the principle of diagnosing before prescribing.

Shared workshops and educational content can still be valuable, but company-level support should respond to the specific risks and priorities of each startup.

Within Juan Damia’s De-Risking Startups Framework™, those risks are examined across Founder, Team, Market, Product, Business Operations, and Finance.

The objective is not to identify every possible weakness. It is to determine which risks and assumptions deserve attention now.

That diagnosis creates the basis for measuring progress later.

If the accelerator never establishes what needed to improve, it becomes difficult to determine whether the intervention worked.

Define Prioritized Actions

Diagnosis should lead to action.

If a startup has weak evidence of customer urgency, its priority may be validating market assumptions. If the company has strong demand but insufficient operational capacity, its priorities will be different. If runway is becoming dangerous, financial actions may deserve immediate attention.

These priorities can be translated into concrete actions with expected outcomes and target dates.

This creates an important connection between startup assessment and execution:

Baseline → Risk identified → Priority → Action → Evidence → Reassessment

Now the accelerator can measure more than whether the founder was active.

It can measure whether the founder worked on the issues that mattered most and whether that work changed the company.

Measure Completion, but Put It in Context

Completion of prioritized actions is an important accelerator KPI, but it should not be confused with progress itself.

A founder may complete every assigned action without producing the expected result. Another may run an experiment that invalidates a critical assumption and forces the startup to reconsider its strategy.

The second outcome can represent substantial progress even though the original hypothesis was wrong.

This is why accelerators should measure both execution and what was learned from execution.

Did the startup complete the action?

What evidence did it generate?

Did that evidence validate or challenge an important assumption?

Did the founders change a decision as a result?

Did the underlying risk decrease?

Completion tells the accelerator that work happened. Evidence and reassessment help determine whether the work changed the startup.

Reassess During the Cohort

An accelerator should not wait until Demo Day to evaluate progress.

Startups change too quickly.

A company can resolve an important risk in the first month and develop another in the second. New evidence can invalidate earlier assumptions. Hiring can create organizational complexity. Growth can expose operational weaknesses. Spending can change the financial outlook.

Periodic reassessment allows the accelerator to update its understanding of each startup throughout the program.

The purpose is not to repeatedly grade founders.

It is to ask:

What changed, what did we learn, and what deserves attention now?

This turns startup measurement into a continuous management process rather than a beginning-and-end reporting exercise.

Measure Changes in Risk

One of the clearest indicators of startup progress is whether important risks are becoming more manageable.

If a startup entered the accelerator with substantial Market uncertainty, has customer evidence reduced that uncertainty? If Product risk was high, has actual customer behavior provided stronger validation? If Finance was a concern, has runway or financial sustainability improved?

Some risks will decrease while others may increase or emerge.

That does not automatically mean the startup is moving backward.

As companies develop, their risk structures change. The important question is whether the founders and accelerator understand those changes and are addressing the right priorities.

Measure Changes in Business Readiness

Business readiness provides another perspective on accelerator startup progress.

Business readiness describes how prepared a startup is to operate, survive, and progress toward sustainable growth based on its current evidence, capabilities, and risks.

Comparing readiness at different points in the accelerator provides a way to measure changes in the underlying company.

A useful view is:

Initial readiness → Current readiness → Progress

This is more informative than simply asking whether the company reached a generic milestone because it recognizes that startups begin from different positions and may need to make progress in different areas.

Measure Evidence, Not Just Outcomes

Accelerators should also recognize that meaningful progress does not always produce immediate revenue, investment, or growth.

Some outcomes take longer than the duration of a cohort.

Evidence can provide an earlier indicator.

A startup may validate customer urgency, demonstrate repeat usage, improve retention, establish more sustainable acquisition economics, validate a pricing assumption, improve operational repeatability, or discover that an important hypothesis was wrong.

These changes matter because they improve the quality of the company’s decisions.

An accelerator should therefore measure not only what startups achieved, but also what important uncertainty they resolved.

Look at Individual Companies and the Cohort

Measuring startup progress at the company level also creates a better view of cohort progress.

Program managers should be able to move from the portfolio to the company:

Cohort → Segment → Startup → Priority

At the cohort level, they can see how many companies are progressing, which startups are at risk, which require attention, how engagement is evolving, and whether business readiness is improving.

At the company level, they can understand why.

This gives accelerator managers something that attendance statistics cannot provide: visibility into the actual condition and trajectory of the startups they support.

Rocketbeet’s Founders OS is designed around this model, combining baseline assessment, risk identification, personalized De-Risking Action Plans, ongoing execution, and reassessment so programs can measure changes at both the startup and cohort level.

Measure the Change, Not Just the Program

Accelerators should still measure attendance, mentoring, workshops, completion rates, and other operational KPIs. They help determine whether the program is being delivered and whether founders are engaging with it.

But those metrics answer a different question.

They tell us what the accelerator did.

Startup progress metrics tell us what changed in the companies.

A stronger model for measuring accelerator performance therefore connects the two:

Baseline → Intervention → Action → Evidence → Reassessment → Measurable change

That creates a much clearer view of whether an accelerator is helping its companies progress.

Attendance shows that founders participated in the accelerator. Progress shows whether the startups became stronger because of what happened during it.